Literature DB >> 7829395

Characteristics of human hepatocellular carcinoma cell lines (Hep-KANO) derived from a non-hepatitic, non-cirrhotic hepatitis B virus carrier.

M Baba1, H Hasegawa, M Nakayabu, S Tamaki, S Watanabe, T Shima, S Suzuki, I Kusano, N Kamada.   

Abstract

We have established two cell lines of hepatocellular carcinoma [Hep-KANO, clone 1 (CL-1) and clone 2 (CL-2)] from tissue obtained at autopsy of a hepatitis B virus (HBV) carrier without histological signs of hepatitis or liver cirrhosis. These cell lines differed considerably from each other in morphology, proliferation pattern, alpha-fetoprotein secretion, albumin synthesis, cytokine secretion, modal chromosome number and transplantability to nude mice. Histologic examinations also revealed differences between them. Amplification of N-myc, L-myc, H-ras, K-ras, N-ras, c-erb-B and c-erb-B-2 and rearrangement of p53 were not found in either of the cell lines. However, CL-1 and CL-2 showed an identical HBV-DNA integration pattern. A 4-fold amplification of c-myc was observed in CL-1, but not in CL-2. Hep-KANO cell lines, CL-1 and CL-2 may be useful in clarifying the question of whether hepatocarcinogenesis is directly caused by HBV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829395      PMCID: PMC5919368          DOI: 10.1111/j.1349-7006.1994.tb02914.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma.

Authors:  H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

2.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

3.  Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone.

Authors:  N Huh; T Utakoji
Journal:  Gan       Date:  1981-02

4.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.

Authors:  F V Chisari; K Klopchin; T Moriyama; C Pasquinelli; H A Dunsford; S Sell; C A Pinkert; R L Brinster; R D Palmiter
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

5.  An international system for human cytogenetic nomenclature (1978) ISCN (1978). Report of the Standing Commitee on Human Cytogenetic Nomenclature.

Authors: 
Journal:  Cytogenet Cell Genet       Date:  1978

6.  Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.

Authors:  A S Kekulé; U Lauer; L Weiss; B Luber; P H Hofschneider
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

7.  Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats.

Authors:  P Nagy; R P Evarts; E Marsden; J Roach; S S Thorgeirsson
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

8.  Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.

Authors:  C Pasquinelli; K Bhavani; F V Chisari
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

9.  Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma.

Authors:  T Watanabe; T Morizane; K Tsuchimoto; Y Inagaki; Y Munakata; T Nakamura; N Kumagai; M Tsuchiya
Journal:  Int J Cancer       Date:  1983-08-15       Impact factor: 7.396

10.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma.

Authors:  J Wang; X Chenivesse; B Henglein; C Bréchot
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

View more
  1 in total

Review 1.  HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site.

Authors:  Dake Zhang; Ke Zhang; Urlike Protzer; Changqing Zeng
Journal:  J Clin Transl Hepatol       Date:  2021-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.